Skip to content

An Exploratory Investigation of a Supplement to Promote Brain Health

An Exploratory Investigation of a Supplement to Promote Brain Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05520424
Enrollment
40
Registered
2022-08-29
Start date
2022-06-15
Completion date
2022-10-30
Last updated
2024-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Change, Memory Deficits, Stress

Keywords

Focus, Memory, Attention, Stress

Brief summary

Providing a combination of synergistic dietary supplements, such as vitamins B6, B12, and folate, as well as curcumin, lemon balm, and American ginseng is hypothesized to promote brain health and aid with brain fog, mental clarity, ability to handle stress, mood, focus, and productivity, as well as promote overall well-being.

Interventions

DIETARY_SUPPLEMENTThe Daily Supplement

The ingredient list of the product includes the following: 400mg of curcumin (Longvida) 300mg of lemon balm extract (Cyracos) 200mg of American ginseng (Cereboost) 50mg of epigallocatechin gallate derived from green tea Organic oat milk powder Phosphatidylserine (SerinAid) (active) B6 (in the form of P5P) Folate (Quatrefolic) B12 Silica (non-active)

Sponsors

Citruslabs
CollaboratorINDUSTRY
Parable
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* In good general health with no major chronic conditions (e.g., diabetes, coronary heart disease, etc.)

Exclusion criteria

* Females who are pregnant or breastfeeding * Anyone currently taking other supplements * Anyone with a known allergic reaction * Previous head trauma * Anyone with chronic diseases such as diabetes, coronary heart disease, or cancer. * Any psychological, mental, or neurodevelopmental disorders * Consumes nicotine or marijuana in any form * Previous or current alcohol addiction * Consume more than 10 drinks per week

Design outcomes

Primary

MeasureTime frameDescription
Perceived changes in mental health symptoms as measured by Questionnaires31 daysQuestionnaires measure perceived changes in mental health symptoms (e.g., anxiety levels, mental clarity) and stress management on a scale of 0 (low levels of mental health symptoms) to 10 (very high levels of mental health symptoms)
Perceived changes in stress management as measured by Questionnaires31 daysQuestionnaires measure perceived changes in stress management on a scale of 0 (poor ability to manage stress) to 10 (excellent ability to manage stress)

Secondary

MeasureTime frameDescription
Changes in Cognitive Functioning31 daysCognitive battery questionnaires measure executive functioning, long term memory, working memory, and attention.

Other

MeasureTime frameDescription
Changes in plasma/serum biomarkers associated with brain health31 daysBiomarkers collected via. blood sample sent to a third party lab. The biomarkers of interest for this trial include hs-CRP, HbA1c, homocysteine, and IL-6.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026